A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

Clinical trial NCT00861510 · COMPLETED

Trial details

NCT number: NCT00861510
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Mantle-cell Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Hairy Cell Waldenstrom Macroglobulinemia Multiple Myeloma

Start date: 2009-03-05
Primary completion: 2012-10-19
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.